0 results available. Select is focused ,type to refine list, press Down to open the menu,
No data available
No data available
No data available
No data available
The chart above depicts the distribution of avg ebit margin forecast (5y) for companies operating in the Healthcare sector in the Developed economic region. Over 1,870 companies were considered in this analysis, and 1,797 had meaningful values. The average avg ebit margin forecast (5y) of companies in the sector is -5,376.8% with a standard deviation of 22,461.0%.
Inozyme Pharma Inc's Avg EBIT Margin Forecast (5y) of -1,858.4% ranks in the 26.6% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 1,871 |
| Included Constituents | 1,797 |
| Min | -209,208.5% |
| Max | 42,263.8% |
| Median | -178.1% |
| Mean | -5,376.8% |
| Standard Deviation | 22,461.0% |
You can find companies with similar avg ebit margin forecast (5y) using this stock screener.